The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development | PR Newswire [Video]

, /PRNewswire/ — GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenScript Biotech Global Forum in London, UK. Since its inaugural session at the J.P. Morgan Healthcare Conference in San Francisco in 2020, the forum has become a significant platform for advancing cell and gene therapy (CGT). This year’s move to Europe underscores GenScript’s commitment to driving the global CGT innovation and fostering international collaboration.

“Putting patients first” is the underlying principle driving progress in the pharmaceutical industry and the inspiration behind this year’s forum. “All our efforts in creating this platform for open dialogue and international collaboration in the CGT industry ultimately aim to address patient needs,” said Jesse Chen, VP of Government Affairs and Corporate Communications at GenScript, in a pre-event interview.

The forum brought together global thought leaders from academia, industry, and investment sectors in CGT to explore the theme …